Increased CD133 and stemness-associated protein levels (β-catenin, Oct4, Sox2, and Nanog) and enhanced sphere size/formation (self-renewal) suggest that DEHP/MEHP treatment promotes colon cancer cell stemness (Figure 5A-5C) [51, 52]. The gene discussed is NANOG; the disease is malignant colon neoplasm.